Okutiars solution ophthalmic moisturizing 0.15% fl. 10 ml

Dosage form

The solution (in the form of a clear liquid) is a sterile, transparent, viscoelastic agent that does not contain preservatives.

Structure

0.15% sodium salt of hyaluronic acid, sodium dihydrogen phosphate, manganese chloride tetrahydrate, sodium hydrogen phosphate, sodium chloride, purified water.

To achieve the optimum pH (6.8-7.6) add hydrochloric acid or sodium hydroxide.

pharmachologic effect

Ocutiars is a sterile, preservative-free ophthalmic solution that protects and moisturizes the ocular surface.

The Ocutiars solution contains only components naturally present in the tissues of the eye, due to which it is close in action to a natural tear: it protects, moisturizes and lubricates the surface of the eye.

Ocutiars can be used when wearing soft or hard contact lenses.

Side effects

As with the use of other eye drops, there may be a slight temporary discomfort in the eyes associated with the instillation of the solution.

If there are any side effects that are not indicated in the instructions, the patient should consult a doctor.

Special storage conditions

Do not freeze.

After the first opening of the bottle, Ocutiars can be used for 6 months.

Special conditions

In the presence of chronic diseases, it is necessary to consult a doctor before using Okutiars solution.

Ocutiars should not be used in case of eye infections.

Due to the risk of contamination of the solution, contact of the tip of the bottle with other surfaces or hands should be avoided

contact of the tip of the bottle with the eye should also be avoided.

Do not use this solution if the seal ring or bottle is damaged.

The solution should not be used concurrently with other ophthalmic agents for topical use.

When using other eye drops, wait at least 5 minutes before instilling Okutiars.

The date of the first opening should be recorded on the vial.

The used bottle, bottle after 6 months after the first opening, or after the expiration date should be disposed of with household waste.

Use in pediatrics

Clinical studies of the use of Okutiars solution in children have not been conducted.

Influence on the ability to drive vehicles and use mechanisms

Ocutiars does not affect the ability to drive and operate machinery.

As with any other ophthalmic agent, short-term blurred vision may occur after instillation.

In this case, it is necessary to wait until vision is fully restored, and only then drive a car or operate mechanical equipment.

Childhood use

Clinical studies of the use of Okutiars solution in children have not been conducted.

Indications

To eliminate symptoms of dry eyes due to:

- keratoconjunctivitis dry (Sjogren's syndrome)

- corneal injury, erosion or corneal surgery

- wearing contact lenses

- changes in hormonal levels (menopause)

- environmental factors (wind, cold, dust, smoke, conditioned, dry or polluted air)

- working at a computer monitor, long driving, long-distance flights

- swimming in chlorinated water.

Contraindications

- hypersensitivity to the components that make up the solution.

At the moment, there is no data on taking the drug during pregnancy.

It is also necessary to refuse from the use of the drug Okutiars during the feeding period.

Dosage

The recommended dose is 1 drop in each eye 1-4 times / day.

or as needed.

Instructions for use

Before the first use, the protective ring must be removed from the cap by pulling on the folding valve.

Remove the protective cap.

Pressing on the bottle on both sides, drop 1 drop into both eyes or contact lenses.

Close the bottle with a protective cap.

After instillation, lightly massaging the eyelids with the eyes closed will help to distribute the solution more quickly over the surface of the eyes.

Dear Clients!

We would like to draw your attention to possible changes in the packaging design.

Delivery is subject to stock availability.

Structure

Hyaluronic acid sodium salt, sodium dihydrogen phosphate, manganese chloride tetrahydrate, sodium hydrogen phosphate, sodium chloride

Specifications

Category

Inflammation

Release form

Solution

Manufacturer country

Germany

Scope of the medicinal product

Eyes

Way of introduction

Into the conjunctival sac

Shelf life after opening

Expiration date 6 months after opening.

Expiration date in days

730

A type

Eye drops

Package weight, g

25

Mode of application

:

The recommended dose is 1 drop in each eye 1-4 times / day.

or as needed.

< br> < br> Instructions for use < br> Before the first use, it is necessary to remove the protective ring from the cap by pulling on the folding valve.

< br> Remove the protective cap.

< br> Pressing on the bottle on both sides, drop 1 drop in both eyes or on contact lenses.

< br> Close the bottle with a protective cap.

< br> After instillation, lightly massaging the eyelids with the eyes closed will help to distribute the solution faster over the eye surface.